$4.56
+2.8%LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
Chairman & Chief Executive Officer
Compensation
$803,459
Chief Accounting Officer & Controller
Chief Acquisition Officer & Head of Customer Acquisition
Compensation
$141,110
Chief Compliance Officer & Deputy General Counsel
Compensation
$411,558
Chief Financial Officer
Compensation
$608,728
Chief Innovation Officer
Compensation
$585,284
Chief Legal Officer, General Counsel & Corporate Secretary
Compensation
$332,000
Chief Marketing Officer
Chief Technology Officer
Compensation
$540,873
Senior Vice President of Patient Experience
During the last 12 months, insiders have sold $4.00M worth of LFMD shares, with no buying activity reported.
0
0.00
0
0.00
+0
+$0
0
0.00
15.0K
54.16K
-54K
-$54K
0
0.00
75.0K
443.76K
-444K
-$444K
0
0.00
275.0K
3.50M
-3.5M
-$3.50M
No buying activity
Benathen Marc David
Officer: Chief Financial Officer
$1.68M
Galluppi Stefan
Officer: Chief Innovation Officer
$1.05M
Schreiber Justin
Director, Officer: Chairman And Ceo
$584K
Alvarez Nicholas P
Officer: Chief Acquisition Officer
$444K
Yecies Eric Harold
Officer: Chief Legal Officer & Gc
$184K
Strong bearish signal with $4.00M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
5 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.
LFMD - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 30, 2026 | April 30, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 28, 2025 | April 28, 2025 | 2025 | |
DEF 14A DEF 14A 2023 N/A | April 29, 2024 | December 31, 2023 | 2023 | |
DEF 14A DEF 14A 2023 N/A | April 28, 2023 | April 28, 2023 | 2023 | |
DEF 14A DEF 14A 2022 N/A | April 29, 2022 | April 29, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | May 12, 2021 | May 12, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | December 07, 2020 | December 07, 2020 | 2020 | |
DEF 14A DEF 14A 2020 N/A | December 16, 2019 | January 10, 2020 | 2020 | |
DEF 14A DEF 14A 2018 N/A | April 20, 2018 | May 24, 2018 | 2018 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.